Search

Author/Creator Patel, Kinnari

1. A multicentre comparison between Child Pugh and Albumin‐Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma. (22nd June 2016)

Authors:
Edeline, Julien; Blanc, Jean‐Frédéric; Johnson, Philip; Campillo‐Gimenez, Boris; Ross, Paul; Ma, Yuk Ting; King, Judy; Hubner, Richard A.; Sumpter, Kate; Darby, Suzanne; Evans, Jeff; Iwuji, Chinenye; Swinson, Daniel; Collins, Peter; Patel, Kinnari; Muazzam, Iqtedar; Palmer, Daniel H.; Meyer, Tim
Journal:
Liver international
Issue:
Volume 36:Number 12(2016)
Page Start:
1821
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial. (November 2019)

Authors:
Joharatnam-Hogan, Nalinie; Cafferty, Fay; Hubner, Richard; Swinson, Daniel; Sothi, Sharmila; Gupta, Kamalnayan; Falk, Stephen; Patel, Kinnari; Warner, Nicola; Kunene, Victoria; Rowley, Sam; Khabra, Komel; Underwood, Tim; Jankowski, Janusz; Bridgewater, John; Crossley, Anne; Henson, Verity; Berkma...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 4:Number 11(2019)
Page Start:
854
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Issue 10073 (11th March 2017)

Authors:
Neoptolemos, John P; Palmer, Daniel H; Ghaneh, Paula; Psarelli, Eftychia E; Valle, Juan W; Halloran, Christopher M; Faluyi, Olusola; O'Reilly, Derek A; Cunningham, David; Wadsley, Jonathan; Darby, Suzanne; Meyer, Tim; Gillmore, Roopinder; Anthoney, Alan; Lind, Pehr; Glimelius, Bengt; Falk, Stephe...
Journal:
Lancet
Issue:
Volume 389:Issue 10073(2017)
Page Start:
1011
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Second-line FOLFOX chemotherapy for advanced biliary tract cancer – Authors' reply. Issue 7 (July 2021)

Authors:
Lamarca, Angela; Palmer, Daniel H; Wasan, Harpreet Singh; Ross, Paul J; Ma, Yuk Ting; Arora, Arvind; Falk, Stephen; Gillmore, Roopinder; Wadsley, Jonathan; Patel, Kinnari; Anthoney, Alan; Maraveyas, Anthony; Iveson, Tim; Waters, Justin S; Hobbs, Claire; Barber, Safia; Ryder, W David; Ramage, John...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 7(2021)
Page Start:
e288
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial. Issue 5 (May 2021)

Authors:
Lamarca, Angela; Palmer, Daniel H; Wasan, Harpreet Singh; Ross, Paul J; Ma, Yuk Ting; Arora, Arvind; Falk, Stephen; Gillmore, Roopinder; Wadsley, Jonathan; Patel, Kinnari; Anthoney, Alan; Maraveyas, Anthony; Iveson, Tim; Waters, Justin S; Hobbs, Claire; Barber, Safia; Ryder, W David; Ramage, John...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 5(2021)
Page Start:
690
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗